115 related articles for article (PubMed ID: 3395666)
1. Bioavailability in human volunteers of three intramuscular formulations of cefonicid: a long-acting cephalosporin.
Brumfitt W; James I; Hamilton-Miller JM; Grady D; Price C
Biopharm Drug Dispos; 1988; 9(3):251-7. PubMed ID: 3395666
[TBL] [Abstract][Full Text] [Related]
2. Cefonicid concentration in lung tissue after intramuscular administration.
Cruciani M; Savio S; Concia E
Int J Clin Pharmacol Res; 1987; 7(6):481-4. PubMed ID: 3440639
[TBL] [Abstract][Full Text] [Related]
3. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
Mini E; Mazzei T; Periti P; Reali EF; Bordonaro P; Balocchini E; Ninu B
Chemioterapia; 1987 Apr; 6(2):95-8. PubMed ID: 3594635
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
[TBL] [Abstract][Full Text] [Related]
5. Parenteral antibiotic therapy at home: experience with intramuscular cefonicid.
Nadworny HA; Markowitz A
Clin Ther; 1987; 10(1):82-91. PubMed ID: 3450394
[TBL] [Abstract][Full Text] [Related]
6. Cross-over study of the pharmacokinetics of cefonicid administered intravenously or intramuscularly to healthy adult humans.
Fourtillan JB; Leroy A; Lefebvre MA; Humbert G; Fillastre JP; Reumont G; Ramis N
Eur J Drug Metab Pharmacokinet; 1985; 10(3):225-30. PubMed ID: 3936717
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cefonicid and cefamandole for the treatment of community-acquired infections of the lower respiratory tract.
Geckler RW; McCormack GD; Goodman JS
Rev Infect Dis; 1984; 6 Suppl 4():S847-52. PubMed ID: 6395275
[TBL] [Abstract][Full Text] [Related]
8. Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.
Wallace RJ; Niefield SL; Waters S; Waters B; Awe RJ; Wiss K; Martin RR; Greenberg SB
Antimicrob Agents Chemother; 1982 Feb; 21(2):231-5. PubMed ID: 7041813
[TBL] [Abstract][Full Text] [Related]
9. Penetration of cefonicid in skin suction blister fluid in healthy volunteers.
Cruciani M; Concia E; Passarella E; Soncini R
Int J Clin Pharmacol Res; 1987; 7(3):225-7. PubMed ID: 3596863
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of cefonicid in children.
Furlanut M; D'Elia R; Riva E; Pasinelli F
Eur J Clin Pharmacol; 1989; 36(1):79-82. PubMed ID: 2917594
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial prophylaxis for arthroplasty: a comparative study of cefonicid and cefazolin.
Davis WA; Kane JG
Orthopedics; 1987 Oct; 10(10):1405-9. PubMed ID: 3317328
[TBL] [Abstract][Full Text] [Related]
12. Absence of disulfiram-type reactions to single and multiple doses of cefonicid: a placebo-controlled study.
McMahon FG; Ryan JR; Jain AK; LaCorte W; Ginzler F
J Antimicrob Chemother; 1987 Dec; 20(6):913-8. PubMed ID: 3440774
[TBL] [Abstract][Full Text] [Related]
13. Cefonicid: a long-acting, second-generation cephalosporin. Antimicrobial activity, pharmacokinetics, clinical efficacy and adverse effects.
Pontzer RE; Kaye D
Pharmacotherapy; 1984; 4(6):325-33. PubMed ID: 6393074
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of cefonicid in serum and its penetration into lung tissue, bronchial mucosa and pleura.
Furlan G; Besa G; Broccali G; Gusmitta A
Int J Clin Pharmacol Res; 1989; 9(1):49-53. PubMed ID: 2707925
[TBL] [Abstract][Full Text] [Related]
15. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
Mini E; Mazzei T; Periti P; Reali EF; Bordonaro P; Balocchini E; Ninu B
Chemioterapia; 1987 Jun; 6(2 Suppl):243-6. PubMed ID: 3509398
[No Abstract] [Full Text] [Related]
16. Penetration of cefonicid into human breast milk and various body fluids and tissues.
Lou MA; Wu YH; Jacob LS; Pitkin DH
Rev Infect Dis; 1984; 6 Suppl 4():S816-20. PubMed ID: 6522923
[TBL] [Abstract][Full Text] [Related]
17. Treatment of urinary tract infections in hospitalized patients: a double-blind comparison of cefonicid and cefamandole.
Cox CE; Jacob LS
Rev Infect Dis; 1984; 6 Suppl 4():S839-43. PubMed ID: 6395273
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysis.
Barriere SL; Gambertoglio JG; Alexander DP; Stagg RJ; Conte JE
Rev Infect Dis; 1984; 6 Suppl 4():S809-15. PubMed ID: 6522922
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability and pain study of cefamandole nafate.
Foster TS; Shrewsbury RP; Coonrod JD
J Clin Pharmacol; 1980; 20(8-9):526-33. PubMed ID: 7000857
[TBL] [Abstract][Full Text] [Related]
20. Effects of cefonicid and other cephalosporin antibiotics on male sexual development in rats.
Manson JM; Zolna LE; Kang YJ; Johnson CM
Antimicrob Agents Chemother; 1987 Jul; 31(7):991-7. PubMed ID: 3662478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
